Explore

Trendline Trendline
Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026

Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026

Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026
Trendline Trendline
Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue

Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue

Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue
Trendline Trendline
FDA Approves BeOne's Beqalzi for Mantle Cell Lymphoma, Expanding Treatment Options

FDA Approves BeOne's Beqalzi for Mantle Cell Lymphoma, Expanding Treatment Options

FDA Approves BeOne's Beqalzi for Mantle Cell Lymphoma, Expanding Treatment Options
Trendline Trendline
Pomerantz Law Firm Investigates Grace Therapeutics for Potential Securities Fraud

Pomerantz Law Firm Investigates Grace Therapeutics for Potential Securities Fraud

Pomerantz Law Firm Investigates Grace Therapeutics for Potential Securities Fraud
Trendline Trendline
FDA Approves BeOne and Taiho Drugs for Blood Cancer Treatment

FDA Approves BeOne and Taiho Drugs for Blood Cancer Treatment

FDA Approves BeOne and Taiho Drugs for Blood Cancer Treatment
Trendline Trendline
BriaCell Advances Prostate Cancer Immunotherapy with New Clinical Supplies

BriaCell Advances Prostate Cancer Immunotherapy with New Clinical Supplies

BriaCell Advances Prostate Cancer Immunotherapy with New Clinical Supplies
Trendline Trendline
Citius Oncology Reports Strong Financial Growth and Strategic Developments in Q2 2026

Citius Oncology Reports Strong Financial Growth and Strategic Developments in Q2 2026

Citius Oncology Reports Strong Financial Growth and Strategic Developments in Q2 2026
Trendline Trendline
Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress

Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress

Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress
Trendline Trendline
FDA Approves BeOne's New Therapy for Mantle Cell Lymphoma

FDA Approves BeOne's New Therapy for Mantle Cell Lymphoma

FDA Approves BeOne's New Therapy for Mantle Cell Lymphoma
Reuters Reuters
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug

US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug

By Deena Beasley and Nancy Lapid May 14 (Reuters) - U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines while they await what they hope will be a speedy FDA approval.
Trendline Trendline
Worksport Reports Significant Revenue Growth and Strategic Expansion in Q1 2026

Worksport Reports Significant Revenue Growth and Strategic Expansion in Q1 2026

Worksport Reports Significant Revenue Growth and Strategic Expansion in Q1 2026
Trendline Trendline
Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase

Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase

Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase